People with HIV are now living longer, and are less likely to die from an AIDS-defining illness. What do we know about their health and quality of life today?
“HIV in the Media” is part of a project Diego Mora Bello is working on as an HRC Global Fellow and a Next Generation Leader with The McCain Institute. HRC’s Global Fellows program seeks to identify outstanding established and emerging LGBTQ leaders from around the world and bring them to Washington, D.C. to work alongside
Three Reasons Why Language is Important in Media Coverage of HIV Read More »
Every five years, Ryan White Care (RWC) requires its programs to prepare new plans to adjust to the changing epidemic. Biomedical advances, such as PrEP and Treatment as Prevention, have changed how people understand HIV. It has become difficult to separate HIV Prevention from Treatment. Florida’s RWC programs have submitted their new five-year plans. This
Miami-Dade Five-year HIV Plan Read More »
The prevalence of resistance to nonnucleoside reverse transcriptase inhibitors among HIV-infected individuals has increased to ‘alarming levels’ in Aruba, reaching 45% in 2015, researchers reported. L. Marije Hofstra, MD, of the department of medical microbiology at the University Medical Center Utrecht, the Netherlands, and colleagues discovered that the increase in resistance is due to a
Prevalence of drug-resistant HIV reaches ‘alarming levels’ in Aruba Read More »
The latest HIV Pulse looks at how HIV affects women in BC, a group that makes up approximately 18% of the population living with HIV in the province. The latest data shows HIV care and treatment for women is improving.
Data on HIV and Women in British Columbia Shows Improvement in Access to Care, Treatment Read More »
We caught up with Gilead‘s Mike Elliott to find out the latest in HIV medication and whether a cure is finally within our reach… HIV capsid inhibitors – what are they and how do they work to attack the virus? Capsid inhibitors are a new class of medicines that have the potential to be used
Gilead on HIV: New research, new treatments and the potential for a cure Read More »
Gilead’s latest antiretroviral drug claims lower side effects, but what about the cost? A new antiretroviral drug will soon be available to Canadian HIV patients, but it comes with a dose of controversy and likely a daunting price tag. Odefsey, the successor to the older Complera, is the latest in Gilead Sciences’ line of anti-HIV
New anti-HIV pill Odefsey comes to Canada Read More »
The Fraser Health STOP HIV/AIDS¨ (Seek and Treat for Optimal Prevention) team is dedicated to the prevention, testing, treatment and provision of support services for all sexually transmitted and blood borne infections, including HIV. The Fraser Health Authority serves 1.8 million people living in communities stretching from Burnaby to White Rock to Hope. A group of outreach nurses shared about their experiences working as part of the STOP team.
A Profile in HIV Outreach – Fraser Health Read More »
Georgia’s HIV infection rate dropped by a 6 percent annual rate from 2008 to 2014, the Centers for Disease Control and Prevention has reported. The state Department of Health said Monday that the decline “is very encouraging news for Georgia as we work to eliminate HIV/AIDS in the state.” Dr. Patrick O’Neal, director of health
Georgia sees significant drop in HIV infection rate Read More »
Latest stats offer ‘encouraging news’ in fight against HIV/AIDS ATLANTA – Georgia’s HIV infection rate dropped by a 6 percent annual rate from 2008 to 2014, the CDC has reported. The state Department of Health said Monday that the decline “is very encouraging news for Georgia as we work to eliminate HIV/AIDS in the state.”
Georgia, national HIV infection rates drop Read More »
